The efficacy of vaccinial immune globulin. A 15-year study.
This survey reports on the use of vaccinial immune globulin in Australia over the last 15 years. Evidence is produced that vaccinial immune globulin has proven efficacious in the prophylaxis and therapy of complications following smallpox vaccination. An indication of the type and frequency of complications following vaccination is provided.
D004485:Eczema / Q000209:etiology; D004892:Erythema Multiforme / Q000209:etiology; D005260:Female; D006306:Health Surveys; D006801:Humans; D007106:Immune Sera; D007116:Immunization, Passive; D008297:Male; D012712:Serum Globulins / Q000627:therapeutic use*; D012900:Smallpox Vaccine / Q000009:adverse effects; D014615:Vaccinia / Q000209:etiology; D014616:Vaccinia virus / Q000276:immunology*
D007106:Immune Sera; D012712:Serum Globulins; D012900:Smallpox Vaccine